Across TCGA pan-cancer cohorts, MTCYBP9 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MTCYBP9’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where MTCYBP9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTCYBP9 is over-expressed in tumor.
LUSC are the cancer types where MTCYBP9 tumor–normal differential expression is most reproducible.